Eye drop ads may mislead, harm elderly

Source:Global Times Published: 2017/12/8 21:33:39

Pharmaceutical companies are misleading consumers by exaggerating the benefits of their products, reports said Friday.

Pharmaceutical firms like Shanghai-listed Zhejiang Shapuaisi Pharmaceutical Company have overhyped their products in repeated commercials on television, radio and the Internet, the Xinhua News Agency reported Friday.

"The overblowing of such 'magic medicines' has severely misled consumers," the report said. Eye experts have flagged their concerns over advertising for the eye drop Shapuaisi, which the company claims can prevent or cure cataracts, according to an article published in the WeChat account Dingxiang Doctor on December 2.

The drops cannot prevent or cure cataracts, the report said, and worse, might make the elderly delay treatment.

Zhejiang Shapuaisi Pharmaceutical sold 28 million eye drops with a revenue of 750 million yuan ($113 million) in 2016, Dingxiang Doctor said.

In response, the company issued a statement on December 3 saying that its eye drops were effective, to a certain extent, in improving eyesight and postponing the development of elderly cataracts.

The China Food and Drug Administration on Wednesday ordered the company conduct clinical trials and submit results within three years.

The firm's stock price slumped 3.45 percent on Wednesday. Trading was suspended on Thursday and Friday. 

Global Times

Posted in: SOCIETY

blog comments powered by Disqus